Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Technology  -  Page 130
Latest

Cal Poly SLO to study Diablo Canyon closure

By   /  Friday, October 6th, 2017  /  Central Coast, Energy, Real Estate, Technology, Top Stories, Top Story, Tourism  /  Comments Off on Cal Poly SLO to study Diablo Canyon closure

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

SimpliPhi Power to provide off-grid energy storage system in New Zealand

By   /  Thursday, October 5th, 2017  /  Energy, Latest news, Technology  /  Comments Off on SimpliPhi Power to provide off-grid energy storage system in New Zealand

Ojai-based SimpliPhi Power announced Oct. 3 that it had contracted with electricity distributor Powerco to build an off-grid renewable energy storage system called Base Power in New Zealand. The system provides supplemental or alternative energy to areas where upgrades to the network were not deemed to be cost effective. After initial trials, Powerco ordered 20 Read More →

Read More →
Latest

Oak Therapeutics touts study results for dissolvable strips

By   /  Thursday, October 5th, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Oak Therapeutics touts study results for dissolvable strips

Oak Therapeutics, based in Oxnard, announced that it completed a study of the use of its dissolvable strips to administer an anti-tuberculosis treatment orally. A 300 milligram dose of isoniazid on the dissolvable strips given to canines entered the bloodstream at a statistically similar rate to commercial tablets, the study found. The company, a subsidiary Read More →

Read More →
Latest

Amgen lawsuit over cholesterol drug will get new trial

By   /  Thursday, October 5th, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen lawsuit over cholesterol drug will get new trial

An Amgen lawsuit against a competing cholesterol drug will get a new trial but sales of the drug will be allowed in the U.S. until a decision is rendered. A federal court of appeals judge threw out a ban on the sale of Praluent, manufactured by New York-based Regeneron Pharmaceuticals and French biotech company Sanofi Read More →

Read More →
Latest

Mannkind stock soars over new label info for Afrezza

By   /  Monday, October 2nd, 2017  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Mannkind stock soars over new label info for Afrezza

Westlake Village biotech company Mannkind received approval to update the prescribing information for its inhalable insulin product, Afrezza, making it easier to market to customers. The new label information clarifies starting and adjusting mealtime dosages, as well as initial and peak effects, and helps the company avoid confusing language, CEO Michael Castagna said in a Read More →

Read More →
Latest

GeoLinks using Silicon Valley-style office to attract employees

By   /  Friday, September 29th, 2017  /  Latest news, Technology, West Ventura County  /  Comments Off on GeoLinks using Silicon Valley-style office to attract employees

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

UCSB researchers get $9 million to develop new brain imaging

By   /  Friday, September 29th, 2017  /  Education, Latest news, Technology  /  Comments Off on UCSB researchers get $9 million to develop new brain imaging

UC Santa Barbara researchers received $9 million to further their efforts to get a better view of the human brain. The National Science Foundation awarded the funding to the Next Generation Multiphoton Neuroimaging Consortium project, or NEMONIC, which includes UCSB researchers John Bowers, Michael Goard and Luke Theogarajan among its team of neuroscientists, electrical engineers, Read More →

Read More →